Rep. Jonathan L. Jackson bought Cardinal Health (CAH)
Rep. Jonathan L. Jackson (D-IL-1) · $50K–$100K · traded Jan 12, 2024
- Transaction
- Bought
- Amount
- $50K–$100K
- Owner
- Joint
- Traded
- Jan 12, 2024
- Disclosed
- Feb 15, 2024
- Days to disclose
- 34
- Asset type
- Stock
- As filed
- Cardinal Health, Inc. Common Stock
- Industry
- Medical - Distribution · Healthcare
Other trades in this filing
- Feb 15, 2024$15K–$50K
$15K–$50K · Traded Jan 19, 2024 · disclosed Feb 15, 2024 · Joint
- Feb 15, 2024$15K–$50K
$15K–$50K · Traded Jan 17, 2024 · disclosed Feb 15, 2024 · Joint
- Feb 15, 2024$1K–$15K
Bought Regeneron Pharmaceuticals REGN
$1K–$15K · Traded Jan 17, 2024 · disclosed Feb 15, 2024 · Joint
- Feb 15, 2024$15K–$50K
$15K–$50K · Traded Jan 8, 2024 · disclosed Feb 15, 2024 · Joint
- Feb 15, 2024$15K–$50K
$15K–$50K · Traded Jan 8, 2024 · disclosed Feb 15, 2024 · Joint
Recent Congress trades in CAH
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Oct 28, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Oct 24, 2025 · disclosed Oct 28, 2025
- May 19, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded May 14, 2025 · disclosed May 19, 2025
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- May 6, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded May 5, 2025 · disclosed May 6, 2025
- Mar 19, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Mar 17, 2025 · disclosed Mar 19, 2025
- Jan 27, 2025$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Jan 21, 2025 · disclosed Jan 27, 2025
- Sep 23, 2024$1K–$15K
Rep. Marjorie Taylor Greene (R-GA-14)
$1K–$15K · Traded Sep 20, 2024 · disclosed Sep 23, 2024
Company context for CAH
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
CAH: third_quarter 2026 lobbying report
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to prov
Public: Oct 20, 2026, 1:54 PM EDTOriginal source ↗CAH: third_quarter 2026 lobbying report
General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs Supply chain issues affecting the pharmaceutical industry
Public: Oct 16, 2026, 3:29 PM EDTOriginal source ↗CAH: second_quarter 2026 lobbying report
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preservin
Public: Jul 20, 2026, 10:07 AM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.